Down-regulation of ANT2 protein levels by shRNA from Targeting Adenine Nucleotide Translocase-2 (ANT2) to Overcome Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor in Non–Small Cell Lung Cancer

Abstract

<p>At 24 h after transfection with ANT2-specific shRNA or sc shRNA, Western blotting was performed to determine the levels of ANT2 and actin as a loading control.</p>